ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,070.55
1.20%
US Tech 100
17,068.80
1.89%
Dow Jones
38,503.69
0.69%
Brent Oil
87.565
1.34%
Bitcoin
66,419.04
-0.66%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Ab Science Sa (0Q77) Quote

Ab Science Sa

Ab Science Sa (0Q77)

LSE
3.835
0.00
(0.00%)
Closed April 23 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.835
Bid
3.74
Ask
3.93
Volume
12
0.00 Day's Range 0.00
3.835 52 Week Range 3.835
Market Cap
92.272M
Previous Close
3.835
Open
-
Last Trade
1
@
1.994
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,980
Shares Outstanding
46,602,000
Dividend Yield
-
PE Ratio
-6.78
Earnings Per Share (EPS)
-0.29
Revenue
958k
Net Profit
-13.62M

About Ab Science Sa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ab-science.com
Headquarters
Paris, Paris, Fra
Founded
1970
Ab Science Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0Q77. The last closing price for Ab Science was 3.84 €. Over the last year, Ab Science shares have traded in a share price range of 3.835 € to 3.835 €.

Ab Science currently has 46,602,000 shares outstanding. The market capitalization of Ab Science is 92.27 € million. Ab Science has a price to earnings ratio (PE ratio) of -6.78.

0Q77 Latest News

More News

AB Science annonce que Santé Canada a jugé admissible la demande de réexamen du masitinib dans SLA

AB Science annonce que Santé Canada a jugé admissible la demande de réexamen du masitinib dans SLA COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE QUE SANTÉ CANADA A JUGÉ ADMISSIBLE LA DEMANDE DE...

April 03 2024
GlobeNewswire Inc.

AB Science : De nouvelles recherches montrent que le masitinib limite les dommages neuronaux dans un modèle de maladie neurodégénérative d’origine neuroimmune

AB Science : De nouvelles recherches montrent que le masitinib limite les dommages neuronaux dans un modèle de maladie neurodégénérative d’origine neuroimmune COMMUNIQUÉ DE PRESSE DE NOUVELLES...

March 13 2024
UK Regulatory

AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease

AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL...

March 13 2024
UK Regulatory

AB Science propose un résumé de la conférence virtuelle qui s’est tenue le 4 mars 2024, avec pour objectif de faire le point sur le développement d'AB Science

AB Science propose un résumé de la conférence virtuelle qui s’est tenue le 4 mars 2024, avec pour objectif de faire le point sur le développement d'AB Science COMMUNIQUÉ DE PRESSE RÉSUMÉ DE...

March 07 2024
UK Regulatory

AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development

AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON MARCH 4, 2024 PROVIDING AN UPDATE...

March 07 2024
UK Regulatory

AB Science annonce l’initiation de la couverture de son titre par deux sociétés d’analyse financières, DNA Finance d’une part, et par In Extenso Finance d’autre part

AB Science annonce l’initiation de la couverture de son titre par deux sociétés d’analyse financières, DNA Finance d’une part, et par In Extenso Finance d’autre part COMMUNIQUE DE PRESSE DEUX...

March 06 2024
UK Regulatory

AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company

AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company PRESS RELEASE TWO NEW FINANCIAL ANALYSIS FIRMS INITIATE COVERAGE...

March 06 2024
UK Regulatory

AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30

AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30 COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 4 MARS 2024, DE 18H30 A 19H30 Paris...

March 01 2024
UK Regulatory

AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET

AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY MARCH 4, 2024 FROM 6.30PM TO 7.30PM CET Paris...

March 01 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.8353.8353.8355803.835DE
4003.8353.8353.83544983.835DE
12003.8353.8353.83539803.835DE
26003.8353.8353.83543023.835DE
52003.8353.8353.835102743.835DE
156003.8353.8353.83557083.835DE
260003.8353.8353.83555583.835DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.223
(46.42%)
6.78M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 6.54
(21.34%)
10.58M
TSLTT Rex 2X Long Tesla Daily Target ETF
$ 8.9203
(21.20%)
2.58M
TSLRGraniteShares ETF Trust GraniteShares
$ 9.80
(20.84%)
274.08k
SHIMShimmick Corporation
$ 3.50
(14.94%)
298.7k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 43.90
(-21.49%)
747.96k
TSDDGraniteShares ETF Trust GraniteShares
$ 28.00
(-21.13%)
175.06k
JYDJayud Global Logistics Ltd
$ 0.865
(-16.83%)
135.69k
CSLRComplete Solaria Inc
$ 0.3721
(-13.47%)
70.34k
KPRXKiora Pharmaceuticals Inc
$ 0.504
(-13.03%)
414.16k
TSLATesla Inc
$ 160.16
(10.70%)
24.2M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 6.54
(21.34%)
10.58M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.223
(46.42%)
6.78M
SQQQProShares UltraPro Short QQQ
$ 11.79
(-1.01%)
4.92M
CYNCYNGN Inc
$ 0.1144
(0.35%)
3.94M

Discussion

View Full Feed
No-Quarter No-Quarter 2 minutes ago
BOIL signal - I got a buy signal on the 60 min chart yesterday (see below). See yellow highlighted area on below chart. Full bar printed above the 9MA , and above the 200MA . I waited until today for confirmation. I bought BOIL today towards EOD. GLTY

https://investorshub.advfn
Involuntary-Recluse Involuntary-Recluse 2 minutes ago
You were right, i shall eat crow now 🦃 or turkey 😂
ASKH
MightyX MightyX 3 minutes ago
TPT lined up their eggs accordingly..couple replaceable eggs cracked, that is all, TPT has grown to know what it takes go from OTC to NASDAQ better than any other company imo. TPT literally put it all out there for the market/traders/investors/retail to do as they wish knowing what they were doing
TPTW
theorysuit theorysuit 3 minutes ago
The NICE Coverage is not even going be an issue. But in event that it is. NICE limits the number of patients (see below for CAR-t). I think the disciples calculate some ridiculous number for UK patients. But sht it is going to be a moot point because this is going to get denied in the approva
NWBO
IceCold8 IceCold8 3 minutes ago
Maybe, that's why he so dependent upon Gov't contracts,he's proving to Uncle Sam, he can do things at a snails pace. I don't know what else to think anymore!
AGSS
Inquirig Inquirig 3 minutes ago
The PIP trials haven't even started yet...
NWBO
Involuntary-Recluse Involuntary-Recluse 3 minutes ago
Has nothing to do with trust TF, we are all responsible for our own trading decisions...
Kudo's to him for taking $$$ off the table if he indeed did so, changes nothing for the rest of us..
ASKH
peafunke peafunke 4 minutes ago
It will. I’m highly confident.

It happened twice before but now they have some incoming milestones that I think they want to align with.

The Q had to be redone before the release of the 10K.

Then we get another Q mid May after another 10 day NT fil
TPTW
TradingCharts TradingCharts 4 minutes ago
6,149 views Apr 20, 2024
You're now listening to the first episode of our latest initiative, the "Unveil the Future" podcast. Our mission is to bridge the gap between science and the public, making it more accessible and easily comprehensible for all. Our hope is that regardless of your back
Grandmasim Grandmasim 4 minutes ago
Mr. Sloppy, DD Master, said each of the prior 10 years was their year though.......
VDRM
StayHumble StayHumble 4 minutes ago
Commision🔥Drops$DBMMcase dueto Data Leak Mistake🔥 $DBMM! Digital Brand Media & Marketing Group, Inc.
Intellicell Biosciences, Inc. 3-17990
https://www.sec.gov/litigation/opinions/2023/33-11198.pdf
Minimum 4 Fraud Cases!
"Not Kramer but a Fraud Asscociate"
DBMM DBMMCASE
SSKILLZ1 SSKILLZ1 4 minutes ago
My Take on last night's show

Well here is my take on last night's show.

1) Abi- Singing a TS Song. Started off a little slow and boring. Than when she got to the middle to end it was a bit pitchey in parts. She has been much better alot of times, including on sunday whe
bwmgftw bwmgftw 4 minutes ago
https://investorshub.advfn.com/boards/breakoutboards.aspx #2. Well done Hippy and your alt accounts. I cheers to you.
PSRU
newmedman newmedman 5 minutes ago
It's hard sometimes when you know you are part of the problem. We all cant be part of the solution, we find solace in better days that will never come but hope for a better moment if not for ourselves but our families

[yt]YDVAQI-4lto[/yt]
Shekiboy Shekiboy 5 minutes ago
2 paragraphs of unintelligible nonsense and contradiction...

Enter hype into your algorithms and maybe you'll get to 90.


Keep your chin up.


Good luck junior.
SPZI
Money4Nothing-M4N Money4Nothing-M4N 5 minutes ago
Well, whatever they’re doing, I’d like to see a marketing campaign get started by someone.

The news lately is fantastic but it seems to be exciting only for those of us in this echo chamber.

Plus side of that is realizing that we are sitting on a volcano.
KBLB
Grandmasim Grandmasim 5 minutes ago
Of course 😂 🤡
VDRM
OMOLIVES OMOLIVES 5 minutes ago
I am not talking about individuals adjusting spending. Keynesian theory suggests that the "Government" adjusts spending. They clearly do not:

https://investorshub.advfn.com/uimage/uploads/2024/4/23/mmbgxCapture.PNG


https://investorshub.advfn.com/uimage/uploads
Involuntary-Recluse Involuntary-Recluse 6 minutes ago
Delusional dreamers lounge ;-) 😂
ASKH
No-Quarter No-Quarter 6 minutes ago
I'm with you. If we have another day tomorrow like yesterday and today, I will look for a full candle to be printed above the 9MA on all of the Big Three. I highlighted the target areas in yellow on below charts. We will see what tomorrow brings... GLTY

https://investorshub.advfn.
WOOFERHEAD WOOFERHEAD 6 minutes ago
I'm reposting this post. The date below in red was the commencement date May 11 2023 of agreements. One year from that date puts us at a due date of May 11 2024.

I expect news soon. From 8K dated 5-11-23 page 22. (Still expecting news soon.)

https://www.otcmark
BOPO
bwmgftw bwmgftw 7 minutes ago
Check out the weekly volume. It is real nice. Of course monthly volume is king. We are set for recognition very soon.
PSRU
Box Money Box Money 7 minutes ago
Riiight
BCAP
bwmgftw bwmgftw 7 minutes ago
I am keeping 80% of my position for .0003 +. If I didn't need cash I wouldn't even sell the 20% at .0002. 3/5ths of that 20% I will have to sell at .0002 came from .00005 so that is a plus (benefits of buying when others are scared, sometimes you get dilution fills). My point is I think most big boy
PSRU

Your Recent History

LSE
0Q77
Ab Science
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved